These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26202034)

  • 1. Circulating free DNA in the progression of liver damage to hepatocellular carcinoma.
    Piciocchi M; Cardin R; Vitale A; Vanin V; Giacomin A; Pozzan C; Maddalo G; Cillo U; Guido M; Farinati F
    Hepatol Int; 2013 Oct; 7(4):1050-7. PubMed ID: 26202034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total serum DNA and DNA integrity: diagnostic value in patients with hepatitis B virus-related hepatocellular carcinoma.
    Chen H; Sun LY; Zheng HQ; Zhang QF; Jin XM
    Pathology; 2012 Jun; 44(4):318-324. PubMed ID: 28193336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total serum DNA and DNA integrity: diagnostic value in patients with hepatitis B virus-related hepatocellular carcinoma.
    Chen H; Sun LY; Zheng HQ; Zhang QF; Jin XM
    Pathology; 2012 Jun; 44(4):318-24. PubMed ID: 22531347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Cell-Free DNA and DNA Integrity as Molecular Diagnostic Tools in Hepatocellular Carcinoma.
    Elzehery R; Effat N; El Farahaty R; Elsayed Farag R; Abo-Hashem EM; Elhelaly R
    Am J Clin Pathol; 2022 Aug; 158(2):254-262. PubMed ID: 35403666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the cell-free DNA integrity index as a liquid biopsy marker to differentiate hepatocellular carcinoma from chronic liver disease.
    Kumar S; Nadda N; Paul S; Gamanagatti S; Dash NR; Vanamail P; Saraya A; Shalimar ; Nayak B
    Front Mol Biosci; 2022; 9():1024193. PubMed ID: 36483538
    [No Abstract]   [Full Text] [Related]  

  • 6. Relation between serum levels of cell-free DNA and inflammation status in hepatitis C virus-related hepatocellular carcinoma.
    Iida M; Iizuka N; Sakaida I; Moribe T; Fujita N; Miura T; Tamatsukuri S; Ishitsuka H; Uchida K; Terai S; Tokuhisa Y; Sakamoto K; Tamesa T; Miyamoto T; Hamamoto Y; Oka M
    Oncol Rep; 2008 Oct; 20(4):761-5. PubMed ID: 18813815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
    World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma.
    Zhao Y; Xue F; Sun J; Guo S; Zhang H; Qiu B; Geng J; Gu J; Zhou X; Wang W; Zhang Z; Tang N; He Y; Yu J; Xia Q
    Clin Epigenetics; 2014; 6(1):30. PubMed ID: 25859288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma.
    Hosny G; Farahat N; Hainaut P
    Cancer Lett; 2009 Mar; 275(2):234-9. PubMed ID: 19046801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease.
    Szpechcinski A; Chorostowska-Wynimko J; Struniawski R; Kupis W; Rudzinski P; Langfort R; Puscinska E; Bielen P; Sliwinski P; Orlowski T
    Br J Cancer; 2015 Jul; 113(3):476-83. PubMed ID: 26125447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical value of total plasma cell-free DNA in hepatitis B virus-related hepatocellular carcinoma.
    Wang D; Hu X; Long G; Xiao L; Wang ZM; Zhou LD
    Ann Transl Med; 2019 Nov; 7(22):650. PubMed ID: 31930051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases.
    Hosny G; Farahat N; Tayel H; Hainaut P
    Cancer Lett; 2008 Jun; 264(2):201-8. PubMed ID: 18313840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a novel panel of somatic mutations in plasma cell-free DNA and its diagnostic value in hepatocellular carcinoma.
    Xiong Y; Xie CR; Zhang S; Chen J; Yin ZY
    Cancer Manag Res; 2019; 11():5745-5756. PubMed ID: 31303788
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma cell-free DNA for predicting outcomes of patients with HBV-related acute-on-chronic liver failure: a pilot study.
    Li F; Yan T; Li K; Mu J; Su H; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):147-52. PubMed ID: 24589586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC).
    Lee T; Rawding PA; Bu J; Hyun S; Rou W; Jeon H; Kim S; Lee B; Kubiatowicz LJ; Kim D; Hong S; Eun H
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
    Mondal G; Saroha A; Bose PP; Chatterjee BP
    Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma.
    Huang A; Zhang X; Zhou SL; Cao Y; Huang XW; Fan J; Yang XR; Zhou J
    J Cancer; 2016; 7(13):1798-1803. PubMed ID: 27698918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Alterations of Circulating Cell-Free DNA in the Pathological Progression of Hepatocellular Carcinoma.
    Guo W; Lu J; Yan L; Sun D; Gong L; Shi W
    J Oncol; 2021; 2021():3637436. PubMed ID: 34899905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer.
    Kumari S; Tewari S; Husain N; Agarwal A; Pandey A; Singhal A; Lohani M
    Pathol Oncol Res; 2017 Jan; 23(1):91-97. PubMed ID: 27475647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients.
    Choy LYL; Peng W; Jiang P; Cheng SH; Yu SCY; Shang H; Olivia Tse OY; Wong J; Wong VWS; Wong GLH; Lam WKJ; Chan SL; Chiu RWK; Chan KCA; Lo YMD
    Clin Chem; 2022 Sep; 68(9):1151-1163. PubMed ID: 35587130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.